Gallic acid (GA) exhibits a broad range of biological activities; however, its clinical application is significantly limited by poor stability, rapid degradation, and low bioavailability. Consequently, developing responsive delivery platforms to enhance GA stability and targeted release has become an important research focus.
[...] Read more.
Gallic acid (GA) exhibits a broad range of biological activities; however, its clinical application is significantly limited by poor stability, rapid degradation, and low bioavailability. Consequently, developing responsive delivery platforms to enhance GA stability and targeted release has become an important research focus. Herein, GA was encapsulated within novel composite hydrogel beads (CMC-SA-Fe
3O
4@GA) prepared via crosslinking carboxymethyl chitosan (CMC) and sodium alginate (SA) with Fe
3O
4 nanoparticles (NPs) to facilitate efficient drug delivery. The formulation was characterized and evaluated in terms of drug-loading capacity, controlled-release properties, antioxidant activity, antibacterial performance, and biocompatibility. The results indicated that the GA loading efficiency reached 31.07 ± 1.23%. Application of an external magnetic field accelerated GA release, with the observed release kinetics fitting the Ritger–Peppas model. Furthermore, antioxidant capacity, evaluated by DPPH assays, demonstrated excellent antioxidant activity of the CMC-SA-Fe
3O
4@GA composite beads. Antibacterial tests confirmed sustained inhibitory effects against
Escherichia coli and
Staphylococcus aureus. In vitro, cellular assays indicated favorable biocompatibility with normal hepatic cells (HL-7702) and effective inhibition of hepatocellular carcinoma cells (HepG2). Overall, the novel pH- and magnetic field-responsive CMC-SA-Fe
3O
4@GA hydrogel system developed in this work offers considerable potential for controlled delivery of phenolic compounds, demonstrating promising applicability in biomedical and food-related fields.
Full article